Pascal A T Baltzer1. 1. Universitätsklinik für Radiologie und Nuklearmedizin, allgemeines Krankenhaus der Medizinischen Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Österreich. pascal.baltzer@meduniwien.ac.at.
Abstract
CLINICAL/METHODOLOGICAL ISSUE: Central to breast imaging is the coordination of clinical and multimodal imaging information with percutaneous image-guided biopsies and surgical procedures. A wide range of problems arise due to this complexity: missed cancers, overdiagnosis, false-positive findings, unnecessary further imaging, biopsies and surgeries. STANDARD RADIOLOGICAL METHODS: Breast imaging comprises the following diagnostic tests: mammography, tomosynthesis, contrast-enhanced mammography, (multiparametric) ultrasound, magnetic resonance imaging, computed tomography, nuclear medicine derived imaging and hybrid methods. METHODOLOGICAL INNOVATIONS: Artificial intelligence (AI) promises to alleviate practically all these problems of breast imaging. AI has the potential to avoid missed cancers and false-positive findings. Furthermore, it could guide an efficient use of imaging methods and it may potentially be used to define biological phenotypes of breast cancer. PERFORMANCE: AI-based software is being developed for various applications. Most developed are systems that support mammography screening. Problems are monocentric approaches and the focus on short-term financial success. ACHIEVEMENTS: AI promises to improve breast imaging by simplifying and speeding up the workflow, by reducing monotonous tasks and by pointing out problems. This is likely to set free physician capacities that could be invested in improved communication with patients and interdisciplinary colleagues. PRACTICAL RECOMMENDATIONS: The present article mainly addresses clinical needs in breast imaging, pointing out potential areas of use for artificial intelligence. Depending on the definition, a wide array of helpful software tools for breast imaging are already available. Global solutions, however, are still missing.
CLINICAL/METHODOLOGICAL ISSUE: Central to breast imaging is the coordination of clinical and multimodal imaging information with percutaneous image-guided biopsies and surgical procedures. A wide range of problems arise due to this complexity: missed cancers, overdiagnosis, false-positive findings, unnecessary further imaging, biopsies and surgeries. STANDARD RADIOLOGICAL METHODS: Breast imaging comprises the following diagnostic tests: mammography, tomosynthesis, contrast-enhanced mammography, (multiparametric) ultrasound, magnetic resonance imaging, computed tomography, nuclear medicine derived imaging and hybrid methods. METHODOLOGICAL INNOVATIONS: Artificial intelligence (AI) promises to alleviate practically all these problems of breast imaging. AI has the potential to avoid missed cancers and false-positive findings. Furthermore, it could guide an efficient use of imaging methods and it may potentially be used to define biological phenotypes of breast cancer. PERFORMANCE: AI-based software is being developed for various applications. Most developed are systems that support mammography screening. Problems are monocentric approaches and the focus on short-term financial success. ACHIEVEMENTS: AI promises to improve breast imaging by simplifying and speeding up the workflow, by reducing monotonous tasks and by pointing out problems. This is likely to set free physician capacities that could be invested in improved communication with patients and interdisciplinary colleagues. PRACTICAL RECOMMENDATIONS: The present article mainly addresses clinical needs in breast imaging, pointing out potential areas of use for artificial intelligence. Depending on the definition, a wide array of helpful software tools for breast imaging are already available. Global solutions, however, are still missing.
Entities:
Keywords:
Breast cancer; Early diagnosis; Mammography; Precision medicine; Software
Authors: Marije F Bakker; Stéphanie V de Lange; Ruud M Pijnappel; Ritse M Mann; Petra H M Peeters; Evelyn M Monninkhof; Marleen J Emaus; Claudette E Loo; Robertus H C Bisschops; Marc B I Lobbes; Matthijn D F de Jong; Katya M Duvivier; Jeroen Veltman; Nico Karssemeijer; Harry J de Koning; Paul J van Diest; Willem P T M Mali; Maurice A A J van den Bosch; Wouter B Veldhuis; Carla H van Gils Journal: N Engl J Med Date: 2019-11-28 Impact factor: 91.245
Authors: Johanna O P Wanders; Katharina Holland; Wouter B Veldhuis; Ritse M Mann; Ruud M Pijnappel; Petra H M Peeters; Carla H van Gils; Nico Karssemeijer Journal: Breast Cancer Res Treat Date: 2016-12-23 Impact factor: 4.872
Authors: Francesco Sardanelli; Hildegunn S Aase; Marina Álvarez; Edward Azavedo; Henk J Baarslag; Corinne Balleyguier; Pascal A Baltzer; Vanesa Beslagic; Ulrich Bick; Dragana Bogdanovic-Stojanovic; Ruta Briediene; Boris Brkljacic; Julia Camps Herrero; Catherine Colin; Eleanor Cornford; Jan Danes; Gérard de Geer; Gul Esen; Andrew Evans; Michael H Fuchsjaeger; Fiona J Gilbert; Oswald Graf; Gormlaith Hargaden; Thomas H Helbich; Sylvia H Heywang-Köbrunner; Valentin Ivanov; Ásbjörn Jónsson; Christiane K Kuhl; Eugenia C Lisencu; Elzbieta Luczynska; Ritse M Mann; Jose C Marques; Laura Martincich; Margarete Mortier; Markus Müller-Schimpfle; Katalin Ormandi; Pietro Panizza; Federica Pediconi; Ruud M Pijnappel; Katja Pinker; Tarja Rissanen; Natalia Rotaru; Gianni Saguatti; Tamar Sella; Jana Slobodníková; Maret Talk; Patrice Taourel; Rubina M Trimboli; Ilse Vejborg; Athina Vourtsis; Gabor Forrai Journal: Eur Radiol Date: 2016-11-02 Impact factor: 5.315
Authors: Andreas Pettersson; Rebecca E Graff; Giske Ursin; Isabel Dos Santos Silva; Valerie McCormack; Laura Baglietto; Celine Vachon; Marije F Bakker; Graham G Giles; Kee Seng Chia; Kamila Czene; Louise Eriksson; Per Hall; Mikael Hartman; Ruth M L Warren; Greg Hislop; Anna M Chiarelli; John L Hopper; Kavitha Krishnan; Jingmei Li; Qing Li; Ian Pagano; Bernard A Rosner; Chia Siong Wong; Christopher Scott; Jennifer Stone; Gertraud Maskarinec; Norman F Boyd; Carla H van Gils; Rulla M Tamimi Journal: J Natl Cancer Inst Date: 2014-05-10 Impact factor: 13.506